I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 52 300 VND -0.38% Market Closed
Market Cap: 8.1T VND

Operating Margin
Imexpharm Corp

18.5%
Current
17%
Average
5.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.5%
=
Operating Profit
454.6B
/
Revenue
2.5T

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
VN
Imexpharm Corp
VN:IMP
8.1T VND
19%
US
Eli Lilly and Co
NYSE:LLY
1T USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
504.1B USD
27%
CH
Roche Holding AG
SIX:ROG
269.2B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
215.1B GBP
24%
CH
Novartis AG
SIX:NOVN
216.4B CHF
33%
US
Merck & Co Inc
NYSE:MRK
269.1B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
42%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
11%
US
Pfizer Inc
NYSE:PFE
142.6B USD
29%
No Stocks Found

Imexpharm Corp
Glance View

Market Cap
8.1T VND
Industry
Pharmaceuticals

Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

IMP Intrinsic Value
44 118.1 VND
Overvaluation 16%
Intrinsic Value
Price
I
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.5%
=
Operating Profit
454.6B
/
Revenue
2.5T
What is the Operating Margin of Imexpharm Corp?

Based on Imexpharm Corp's most recent financial statements, the company has Operating Margin of 18.5%.

Back to Top